Biopharmaceutical Logistics Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 – 2032

Biopharmaceutical Logistics Market size is slated to register a substantial gains trajectory during the period 2023-2032 due to the surging adoption of temperature-regulated transportation of critical drugs and therapeutics.
 

The rapid deployment of various next-generation technologies has led to the demand for production techniques associated with complex proteins, biologics, hormone medications, vaccines, and temperature-specific byproducts. The upsurge in the incidences of metabolic disorders and cancers is accelerating the need for complex and more advanced therapeutics, emphasizing the need for a controlled environment during transportation. This trend is likely to drive biopharmaceutical logistics market expansion.
 

According to the EY-FICCI 2022 study, the number of cancer cases reported in India was estimated to reach 1.9 to 2 million in 2022. This growing cancer disease burden in India is likely to represent lucrative demand for effective diagnostics and therapeutics, fueling the need for proper transportation and logistics.
 

The COVID-19 pandemic had a moderate impact on the biopharmaceutical logistics industry with the emergence of new challenges and opportunities. In addition to unprecedented supply chain vulnerabilities, the outbreak encouraged extensive clinical trials and R&D activities for the development of novel vaccines. This scenario is continuing to prompt massive investments in biopharmaceuticals, thus propelling the demand for cold chain logistics in the post-pandemic era.
 

With respect to supply chain, the biopharmaceutical logistics market share from cold chain logistics is anticipated to experience a significant boost through 2032 due to the increasing production of temperature-controlled biologics and pharma products. The ease of compliance of temperature-sensitive products will foster demand for cold chain services. Moreover, the rapid integration of telematics in the cold chain is allowing operators to strengthen the safety, connectivity, and efficiency of cargo.
 

Based on service, the warehouse and storage segment in the biopharmaceutical logistics market is projected to depict exponential outlook over 2032 owing to the growing logistics requirements across the healthcare and pharmaceutical sectors. Newly trending services such as third-party logistics will pick pace as they help minimize overheads and OPEX. Furthermore, the increasing use of robots and barcode scanners for streamlined and more efficient supply chain management will complement the industry outlook.
 

Regionally, the Asia Pacific biopharmaceutical logistics industry size is predicted to expand at a notable rate from 2023-2032 led by the solid footprint of pharma giants. With a massive population and a constantly growing geriatric patient pool, countries such as China, and India are fostering lucrative demand for medicines and therapeutics. The rising rate of generic and critical drug export is another important trend for industry revenue.
 

Some major companies in the biopharmaceutical logistics market include KUEHNE + NAGEL, SF Express, FedEx, DHL International GmbH, AmerisourceBergen Corporation, United Parcel Service of America, Inc., Kerry Logistics Network Limited, DB Schenker, and Agility, among others. These competitors are entering new collaborations and partnerships to boost their capabilities and strengthen their business presence.
 

What Information does this report contain?